Company Overview and News


Add GSK
to your dashboard

Headline News

3 Drug/Biotech Stocks in Focus on World AIDS Day

2017-12-01 zacks
Every year, World Aids Day is celebrated on Dec 1 to raise public awareness about Acquired Immuno Deficiency Syndrome, popularly known as AIDS. The day is observed to make people aware about proper cure and prevention of the disease. In this regard, this year, the theme for the day this year is "Right to Health." This day also commemorates those who have died from an AIDS-related illness. (81-0)

Gilead & 3 Other Drug Stocks in Focus this World AIDS Day

2017-12-01 zacks
World AIDS Day takes place every year on December 1 with people across the world coming together to fight against HIV, to support those living with HIV and to commemorate those who have died from an AIDS-related disease. Everybody Counts The slogan for this World AIDS Day is “Everybody Counts”. The goal is to ensure access to affordable and high quality care and services for people with HIV, a strong health care system, as well as the integration of HIV, tuberculosis and hepatitis services. (40-0)

Glaxo Begins Phase III Study on Injection to Prevent HIV

2017-12-01 zacks
GlaxoSmithKline plc (GSK - Free Report) has announced the start of a large late-stage African study on an experimental long-acting injection for the prevention of HIV. ViiV Healthcare, an HIV company majorly owned by Glaxo and Pfizer (PFE - Free Report) , said that the phase III study, HPTN 084, will evaluate long-acting cabotegravir monotherapy for the prevention of HIV infection in sexually active women. (23-0)

Pharma Stock Roundup: Pfizer/Merck KGaA Drug Fails in Study, Teva CEO Announces Changes

2017-12-01 zacks
While reports about tech giant Amazon meeting generic drugmakers made the rounds, companies like Pfizer (PFE - Free Report) and Teva Pharmaceutical Industries Ltd.’s (TEVA - Free Report) were in the news with the former reporting late-stage data and the latter announcing leadership and organizational changes. Recap of the Week’s Most Important Stories Is Amazon in Talks with Generic Drugmakers? According to a CNBC report, tech giant Amazon is in preliminary discussions with generic drugmakers including Mylan (MYL - Free Report) and Novartis’s generic arm, Sandoz, about entering the pharmacy market. (143-0)

Glaxo Stock Down So Far This Year: Is a Reversal in Store?

2017-11-30 zacks
GlaxoSmithKline plc’s (GSK - Free Report) shares have declined 7.9% this year so far, underperforming the 16.2% increase witnessed by the industry. (12-0)

Your Daily Pharma Scoop: Valeant's B+L In India, TXMD's NDA Resubmission, Melinta Makes An Acquisition

2017-11-30 seekingalpha
We discuss Bausch and Lomb’s India sales, and whether that has any bearing on Valeant’s woes. (486-1)

The New Merrimack Is A Possible ROTY Runner For 2018

2017-11-30 seekingalpha
After a reverse split, beefing up the executive line-up and paying down debt, the "new Merrimack" actually merits further due diligence. (28-0)

GSK starts big African study of injectable drug to prevent HIV - Channel NewsAsia

2017-11-30 channelnewsasia
REUTERS: ViiV Healthcare, GlaxoSmithKline Plc's HIV unit, said on Thursday (Nov 30) it started an African study to evaluate long-acting injectable drug for the prevention of HIV infection in sexually active women. (3-0)

GSK starts big African study of injectable drug to prevent HIV

2017-11-30 reuters
(Reuters) - ViiV Healthcare, GlaxoSmithKline Plc’s HIV unit, said on Thursday it started an African study to evaluate long-acting injectable drug for the prevention of HIV infection in sexually active women. (3-0)

Glaxo Submits NDA for Anti Relapse Malaria Medicine to FDA

2017-11-29 zacks
GlaxoSmithKline plc (GSK - Free Report) in partnership with Medicines for Malaria Venture (MMV) filed a new drug application (NDA) with the FDA looking for approval of a single-dose tafenoquine to treat relapsing malaria. (39-0)

Glaxo, Pfizer's ViiV Healthcare Begins HIV Drug Combo Study

2017-11-28 zacks
GlaxoSmithKline (GSK - Free Report) along with partner Pfizer, Inc. (PFE - Free Report) announced that its HIV-focused company, ViiV Healthcare, has initiated a phase III program to evaluate combination of long-acting, injectable cabotegravir and Johnson & Johnson’s (JNJ - Free Report) rilpivirine for treating adults with virally suppressed HIV-1 infection. (41-0)

Top Analyst Upgrades and Downgrades: AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline, Square and Many More

2017-11-27 247wallst
Stocks were directionless on Monday, with most Americans slowly trickling back into the office after an extended Thanksgiving break. Still, the major U.S. indexes remain close to all-time highs and the trend that has won over and over is for investors to buy every pullback. Investors continue to look for new investing and trading ideas to generate gains and income ahead. (89-1)

The Zacks Analyst Blog Highlights: Union Pacific, Alibaba, GlaxoSmithKline, eBay and Welltower

2017-11-27 zacks
Chicago, IL – November 27, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Union Pacific (UNP - Free Report) , Alibaba (BABA - Free Report) , GlaxoSmithKline (GSK - Free Report) , eBay (EBAY - Free Report) and Welltower (HCN - Free Report) . (49-0)

The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, GlaxoSmithKline and Roche

2017-11-27 zacks
Chicago, IL – November 27, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (JNJ - Free Report) , Novartis (NVS - Free Report) , GlaxoSmithKline (GSK - Free Report) and Roche (RHHBY - Free Report) . (50-1)

Top Research Reports for Union Pacific, Alibaba & GlaxoSmithKline

2017-11-24 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 11 major stocks, including Union Pacific (UNP), Alibaba (BABA) and GlaxoSmithKline (GSK). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. (64-0)

CUSIP: 37733W105